Profile
Jan Feijen is the founder of Medisse BV, which was founded in 2006.
He held the title of Scientific Advisor from 2006 to 2013.
Dr. Feijen's former jobs include being the VP-Manufacturing & Technical Operations at Janssen Global Services LLC and the Chief Operations Officer at Kiadis Pharma NV from 2017 to 2019.
Dr. Feijen's education includes a graduate degree from Delft University of Technology and a doctorate degree from the University of Groningen, which was conferred in 1970.
Former positions of Jan Feijen
Companies | Position | End |
---|---|---|
KIADIS PHARMA N.V. | Chief Operating Officer | 2019-03-05 |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Medisse BV
Medisse BV Medical SpecialtiesHealth Technology Medisse BV develops resorbable medical implants based on a flexible material. Its products include FlexiSurge Adhesion Barrier, Hernia Mesh and Scleral Buckle. The company was founded by Sandra de Vos, Dirk W. Grijpma and Jan Feijen in 2006 and is headquartered in Ede, the Netherlands. | Founder | - |
Training of Jan Feijen
Delft University of Technology | Graduate Degree |
University of Groningen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Medisse BV
Medisse BV Medical SpecialtiesHealth Technology Medisse BV develops resorbable medical implants based on a flexible material. Its products include FlexiSurge Adhesion Barrier, Hernia Mesh and Scleral Buckle. The company was founded by Sandra de Vos, Dirk W. Grijpma and Jan Feijen in 2006 and is headquartered in Ede, the Netherlands. | Health Technology |
Kiadis Pharma NV
Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
- Stock Market
- Insiders
- Jan Feijen